GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tipharco Pharmaceutical JSC (HSTC:DTG) » Definitions » Debt-to-Revenue

Tipharco Pharmaceutical JSC (HSTC:DTG) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Tipharco Pharmaceutical JSC Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Tipharco Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Tipharco Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Tipharco Pharmaceutical JSC's annualized Revenue for the quarter that ended in . 20 was ₫0.00 Mil.


Tipharco Pharmaceutical JSC Debt-to-Revenue Historical Data

The historical data trend for Tipharco Pharmaceutical JSC's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tipharco Pharmaceutical JSC Debt-to-Revenue Chart

Tipharco Pharmaceutical JSC Annual Data
Trend
Debt-to-Revenue

Tipharco Pharmaceutical JSC Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Tipharco Pharmaceutical JSC's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Tipharco Pharmaceutical JSC's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tipharco Pharmaceutical JSC's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tipharco Pharmaceutical JSC's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Tipharco Pharmaceutical JSC's Debt-to-Revenue falls into.



Tipharco Pharmaceutical JSC Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Tipharco Pharmaceutical JSC's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Tipharco Pharmaceutical JSC's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Tipharco Pharmaceutical JSC Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tipharco Pharmaceutical JSC's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Tipharco Pharmaceutical JSC (HSTC:DTG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No.15 Doc Binh Kieu Street, Ward 2, Tien Giang, My Tho, VNM
Tipharco Pharmaceutical JSC is engaged in the manufacturing and sale of pharmaceutical products. Its product includes Tiphadocef 100; Tiphanicef ??125; Tihallerdin; Tipha-C and others.

Tipharco Pharmaceutical JSC (HSTC:DTG) Headlines

No Headlines